tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ROIV Stock Latest News

Roivant Sciences Ends Namilumab Study Due to Inefficacy
Company AnnouncementsRoivant Sciences Ends Namilumab Study Due to Inefficacy
18d ago
8K
ROIV
Kinevant says namilumab failed to meet primary endpoint in RESOLVE-Lung study
PremiumThe Fly
Kinevant says namilumab failed to meet primary endpoint in RESOLVE-Lung study
18d ago
ROIV
Roivant Sciences Reports Q2 2024 Financial Results
PremiumCompany Announcements
Roivant Sciences Reports Q2 2024 Financial Results
1M ago
ROIV
Roivant Sciences reports Q2 EPS (31c), consensus (26c)
PremiumThe Fly
Roivant Sciences reports Q2 EPS (31c), consensus (26c)
1M ago
ROIV
ROIV Earnings this Week: How Will it Perform?
PremiumPre-Earnings
ROIV Earnings this Week: How Will it Perform?
1M ago
ROIV
Roivant Sciences Acquires Dermavant, Expanding Dermatology Portfolio
PremiumCompany AnnouncementsRoivant Sciences Acquires Dermavant, Expanding Dermatology Portfolio
2M ago
8K
ROIV
Organon completes acquisition of Dermavant
Premium
The Fly
Organon completes acquisition of Dermavant
2M ago
OGN
ROIV
JPMorgan SMid cap biotech analyst holds an analyst/industry conference call
Premium
The Fly
JPMorgan SMid cap biotech analyst holds an analyst/industry conference call
2M ago
IMVT
ROIV
Eyes on Fed ahead of expected interest rate cut: Morning Buzz
PremiumThe Fly
Eyes on Fed ahead of expected interest rate cut: Morning Buzz
3M ago
X
EA
Organon likely won’t lose money on deal with Roivant, says Evercore ISI
PremiumThe Fly
Organon likely won’t lose money on deal with Roivant, says Evercore ISI
3M ago
OGN
ROIV
Roivant divestment of Dermavant ‘great decision,’ says JPMorgan
PremiumThe Fly
Roivant divestment of Dermavant ‘great decision,’ says JPMorgan
3M ago
OGN
ROIV
Roivant disposal deal good for sentiment and cash burn, says Jefferies
PremiumThe Fly
Roivant disposal deal good for sentiment and cash burn, says Jefferies
3M ago
OGN
IMVT
Roivant Sciences Subsidiary Acquired for $1.2 Billion
PremiumCompany AnnouncementsRoivant Sciences Subsidiary Acquired for $1.2 Billion
3M ago
8K
ROIV
Organon to acquire Dermavant from Roivant Sciences for $1.2B
Premium
The Fly
Organon to acquire Dermavant from Roivant Sciences for $1.2B
3M ago
OGN
ROIV
Organon to acquire Dermavant for consideration up to $1.2B
Premium
The Fly
Organon to acquire Dermavant for consideration up to $1.2B
3M ago
OGN
ROIV
Roivant Sciences price target raised to $12.50 from $12 at BofA
PremiumThe Fly
Roivant Sciences price target raised to $12.50 from $12 at BofA
3M ago
ROIV
3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 9/11/2024, According to Top Analysts 
3M ago
INSM
ROIV
Roivant Sciences Unveils Promising Pulmonary Hypertension Therapy
PremiumCompany Announcements
Roivant Sciences Unveils Promising Pulmonary Hypertension Therapy
3M ago
8K
ROIV
Roivant Sciences’ mosliciguat shows efficacy in pulmonary hypertension trial
PremiumThe Fly
Roivant Sciences’ mosliciguat shows efficacy in pulmonary hypertension trial
3M ago
ROIV
Palantir, Dell Technologies named to join S&P 500: Morning Buzz
PremiumThe FlyPalantir, Dell Technologies named to join S&P 500: Morning Buzz
3M ago
X
BA
Roivant Sciences Reveals Promising Batoclimab Trial Results
Premium
Company Announcements
Roivant Sciences Reveals Promising Batoclimab Trial Results
3M ago
8K
ROIV
Roivant Sciences provides update on Graves’ Disease development program
Premium
The Fly
Roivant Sciences provides update on Graves’ Disease development program
3M ago
IMVT
ROIV

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >